Saturday - May 16, 2026
Temple Health's Fox Chase Cancer Center and Labcorp Collaborate to Test Ultra-Sensitive Blood-Based Assay for Early-Stage Lung Cancer Recurrence Risk
May 05, 2026
PHILADELPHIA, Pennsylvania, May 5 [Category: Health Care] -- The Fox Chase Cancer Center, a part of Temple University Health System, posted the following news:

* * *

Temple Health's Fox Chase Cancer Center and Labcorp Collaborate to Test Ultra-Sensitive Blood-Based Assay for Early-Stage Lung Cancer Recurrence Risk

*

* Labcorp Plasma Detect Genome MRD helps assess and monitor a patient's risk of cancer recurrence by detecting small tr . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products